Asia Pacific Biotechnology Market (2008-2012)
Single User PDF Format: US$ 1,600.00
Multi-User License: US$ 2,400.00
Hard Copy: US$ 1,800.00
CD-ROM: US$ 1,800.00
The Asia Pacific biotechnology market is one with immense potential, which can be tapped through investments driving the infrastructure and R&D in the sector. Investments in the past have been the main reason behind the sustained double digit growth in the biotech sector of the region. The Governments of the Asia Pacific countries also support the biotech industry, as it is a form of comprehensive economic growth. Hence, they are fuelling the industry with several initiatives in terms of financial and regulatory support. Backed by such undying support of the public and private sector, the Asia Pacific biotech sector will continue to grow at a fast pace in future also.
According to our new research report, “Asia Pacific Biotechnology Market (2008-2012)”, the Asia-Pacific biotech market is projected to grow at a CAGR of around 19% during 2010 - 2013. Our research has found that, at the regional forefront, Japan and China are dominating this industry, while higher growth rates have been witnessed in emerging markets, such as Malaysia, India, and Singapore. These countries are anticipated to dominate the market during the next decade.
Thorough analysis of the biotech market in the region suggests the prominence of biosimilars, which will be the background of growth in the industry. Covering almost all the diseases under communicable and non-communicable category, biosimilars will receive a great boost in near future due to the multi-billion dollar worth of patent expiries. On account of this, the major biotech companies in the region are doing their part in developing the generic versions of blockbuster biologics ready to be launched as soon as the patent of a product expires.
The report also provides extensive information and data of the biotech market in the Asia-Pacific region. The report also discusses emerging trends, such as contract research and manufacturing, bioinformatics, generics market etc. Additionally, it has covered the upcoming segment of biobetters, which is the next big thing in the field of biotechnology.
The report further presents valuable information to the pharmaceutical & biotechnology companies and investors, planning to enter these markets and will help them to devise strategies in accordance to the individual markets. The report also contains detail analysis and statistics of the market size, growth, share, segmentation, geographic distribution, trends in technology development, and profiling of key players of each country.
Multi-User License: US$ 2,400.00
Hard Copy: US$ 1,800.00
CD-ROM: US$ 1,800.00
The Asia Pacific biotechnology market is one with immense potential, which can be tapped through investments driving the infrastructure and R&D in the sector. Investments in the past have been the main reason behind the sustained double digit growth in the biotech sector of the region. The Governments of the Asia Pacific countries also support the biotech industry, as it is a form of comprehensive economic growth. Hence, they are fuelling the industry with several initiatives in terms of financial and regulatory support. Backed by such undying support of the public and private sector, the Asia Pacific biotech sector will continue to grow at a fast pace in future also.
According to our new research report, “Asia Pacific Biotechnology Market (2008-2012)”, the Asia-Pacific biotech market is projected to grow at a CAGR of around 19% during 2010 - 2013. Our research has found that, at the regional forefront, Japan and China are dominating this industry, while higher growth rates have been witnessed in emerging markets, such as Malaysia, India, and Singapore. These countries are anticipated to dominate the market during the next decade.
Thorough analysis of the biotech market in the region suggests the prominence of biosimilars, which will be the background of growth in the industry. Covering almost all the diseases under communicable and non-communicable category, biosimilars will receive a great boost in near future due to the multi-billion dollar worth of patent expiries. On account of this, the major biotech companies in the region are doing their part in developing the generic versions of blockbuster biologics ready to be launched as soon as the patent of a product expires.
The report also provides extensive information and data of the biotech market in the Asia-Pacific region. The report also discusses emerging trends, such as contract research and manufacturing, bioinformatics, generics market etc. Additionally, it has covered the upcoming segment of biobetters, which is the next big thing in the field of biotechnology.
The report further presents valuable information to the pharmaceutical & biotechnology companies and investors, planning to enter these markets and will help them to devise strategies in accordance to the individual markets. The report also contains detail analysis and statistics of the market size, growth, share, segmentation, geographic distribution, trends in technology development, and profiling of key players of each country.
1. ANALYST VIEW
2. ASIA-PACIFIC BIOTECHNOLOGY MARKET
2.1 Market Overview
2.1.1 Product Segmentation
2.1.2 Geographical Segmentation
3. INDUSTRY TRENDS
3.1 Developmental and Operational Alliances: The Path of Consolidated Growth
3.2 Asia: The Upcoming Hub of Vaccine R&D and Production
3.3 Biosimilars: Increasing Acceptance in Asia-Pacific
3.4 Agri-Biotech: Fighting Food Security Issues
4. EMERGING SECTORS
4.1 Contract Research and Manufacturing
4.2 Generics
4.3 Stem Cell Research
4.4 Bioinformatics
4.5 Bio-Betters
5. BIOTECHNOLOGY MARKET OUTLOOK TO 2013
5.1 Japan
5.1.1 Market Overview
5.1.2 Drivers and Restraints
5.1.3 Government Regulations and Initiatives
5.1.4 Key Players
5.2 China
5.2.1 Market Overview
5.2.2 Drivers and Restraints
5.2.3 Government Regulations and Initiatives
5.2.4 Key Players
5.3 India
5.3.1 Market Overview
5.3.2 Drivers and Restraints
5.3.3 Government Regulations and Initiatives
5.3.4 Key Players
5.4 Australia
5.4.1 Market Overview
5.4.2 Drivers and Restraints
5.4.3 Government Regulations and Initiatives
5.4.4 Key Players
5.5 Taiwan
5.5.1 Market Overview
5.5.2 Drivers and Restraints
5.5.3 Government Regulations and Initiatives
5.5.4 Key Players
5.6 South Korea
5.6.1 Market Overview
5.6.2 Drivers and Restraints
5.6.3 Government Regulations and Initiatives
5.6.4 Key Players
5.7 New Zealand
5.7.1 Market Overview
5.7.2 Drivers and Restraints
5.7.3 Government Regulations and Initiatives
5.7.4 Key Players
5.8 Singapore
5.8.1 Market Overview
5.8.2 Drivers and Restraints
5.8.3 Government Regulations and Initiatives
5.8.4 Key Players
5.9 Malaysia
5.9.1 Market Overview
5.9.2 Drivers and Restraints
5.9.3 Government Regulations and Initiatives
5.9.4 Key Players
2. ASIA-PACIFIC BIOTECHNOLOGY MARKET
2.1 Market Overview
2.1.1 Product Segmentation
2.1.2 Geographical Segmentation
3. INDUSTRY TRENDS
3.1 Developmental and Operational Alliances: The Path of Consolidated Growth
3.2 Asia: The Upcoming Hub of Vaccine R&D and Production
3.3 Biosimilars: Increasing Acceptance in Asia-Pacific
3.4 Agri-Biotech: Fighting Food Security Issues
4. EMERGING SECTORS
4.1 Contract Research and Manufacturing
4.2 Generics
4.3 Stem Cell Research
4.4 Bioinformatics
4.5 Bio-Betters
5. BIOTECHNOLOGY MARKET OUTLOOK TO 2013
5.1 Japan
5.1.1 Market Overview
5.1.2 Drivers and Restraints
5.1.3 Government Regulations and Initiatives
5.1.4 Key Players
5.2 China
5.2.1 Market Overview
5.2.2 Drivers and Restraints
5.2.3 Government Regulations and Initiatives
5.2.4 Key Players
5.3 India
5.3.1 Market Overview
5.3.2 Drivers and Restraints
5.3.3 Government Regulations and Initiatives
5.3.4 Key Players
5.4 Australia
5.4.1 Market Overview
5.4.2 Drivers and Restraints
5.4.3 Government Regulations and Initiatives
5.4.4 Key Players
5.5 Taiwan
5.5.1 Market Overview
5.5.2 Drivers and Restraints
5.5.3 Government Regulations and Initiatives
5.5.4 Key Players
5.6 South Korea
5.6.1 Market Overview
5.6.2 Drivers and Restraints
5.6.3 Government Regulations and Initiatives
5.6.4 Key Players
5.7 New Zealand
5.7.1 Market Overview
5.7.2 Drivers and Restraints
5.7.3 Government Regulations and Initiatives
5.7.4 Key Players
5.8 Singapore
5.8.1 Market Overview
5.8.2 Drivers and Restraints
5.8.3 Government Regulations and Initiatives
5.8.4 Key Players
5.9 Malaysia
5.9.1 Market Overview
5.9.2 Drivers and Restraints
5.9.3 Government Regulations and Initiatives
5.9.4 Key Players
LIST OF FIGURES:
Figure 2-1: Asia-Pacific - Biotechnology Market (Billion US$), 2010-2013
Figure 2-2: Asia-Pacific - Biotechnology Market by Segment (%), 2010
Figure 2-3: Asia-Pacific - Biotechnology Market by Country (%), 2010
Figure 2-4: Asia-Pacific - Forecast for Biotechnology Market by Country (%), 2013
Figure 4-1: India - Pharma Contract Manufacturing Market (Million US$), 2009-2011
Figure 4-2: Asia-Pacific - Generics Market (Billion US$), 2008-2010
Figure 5-1: Japan - Biotechnology Market (Billion US$), 2008-2013
Figure 5-2: Japan - Biotechnology Market by Segment (%), 2010
Figure 5-3: Japan - Medical and Healthcare Biotechnology Market by Segment (%), 2007
Figure 5-4: Japan - Geographical Distribution of Bio-clusters
Figure 5-5: China - Biotechnology Market (Billion US$), 2008-2013
Figure 5-6: China - Biotechnology Market by Segment (%), 2010
Figure 5-7: India - Biotechnology Market (Billion US$), FY 2009 to FY 2013
Figure 5-8: India - Export and Domestic Consumption of Biotechnology Market (%), FY 2011
Figure 5-9: India - Biotechnology Market by Segment (%), FY 2010
Figure 5-10: India - Biopharmaceutical Market by Segment (%), FY 2007
Figure 5-11: India - Forecast for Biotechnology Market by Segment (%), FY 2013
Figure 5-12: India - Geographical Distribution of Bio-clusters
Figure 5-13: Australia - Biotechnology Market (Billion US$), 2009-2013
Figure 5-14: Australia - Biotechnology Companies by Sector (%), 2010
Figure 5-15: Australia - Geographical Distribution of Bio-clusters
Figure 5-16: Taiwan - Biotechnology Market (Billion NT$), 2008-2013
Figure 5-17: South Korea - Biotechnology Market (Billion US$), 2010-2013
Figure 5-18: South Korea - Biotechnology Market by Segment (%)
Figure 5-19: South Korea - Geographical Distribution of Bio-clusters
Figure 5-20: New Zealand - Biotechnology Market (Million US$), 2009-2013
Figure 5-21: New Zealand - Biotechnology Market by Application (%), 2010
Figure 5-22: New Zealand - Biotechnology Companies by Sector (%), 2007
Figure 5-23: New Zealand - Geographical Distribution of Bio-clusters
Figure 5-24: Singapore - Biotechnology Market (Million US$), 2008-2013
Figure 5-25: Singapore - Geographical Distribution of Bio-clusters
Figure 5-26: Malaysia - Biotechnology Market (Million RM), 2008-2013
Figure 5-27: Malaysia - Biotechnology Industry Investment by Segment (%)
Figure 2-1: Asia-Pacific - Biotechnology Market (Billion US$), 2010-2013
Figure 2-2: Asia-Pacific - Biotechnology Market by Segment (%), 2010
Figure 2-3: Asia-Pacific - Biotechnology Market by Country (%), 2010
Figure 2-4: Asia-Pacific - Forecast for Biotechnology Market by Country (%), 2013
Figure 4-1: India - Pharma Contract Manufacturing Market (Million US$), 2009-2011
Figure 4-2: Asia-Pacific - Generics Market (Billion US$), 2008-2010
Figure 5-1: Japan - Biotechnology Market (Billion US$), 2008-2013
Figure 5-2: Japan - Biotechnology Market by Segment (%), 2010
Figure 5-3: Japan - Medical and Healthcare Biotechnology Market by Segment (%), 2007
Figure 5-4: Japan - Geographical Distribution of Bio-clusters
Figure 5-5: China - Biotechnology Market (Billion US$), 2008-2013
Figure 5-6: China - Biotechnology Market by Segment (%), 2010
Figure 5-7: India - Biotechnology Market (Billion US$), FY 2009 to FY 2013
Figure 5-8: India - Export and Domestic Consumption of Biotechnology Market (%), FY 2011
Figure 5-9: India - Biotechnology Market by Segment (%), FY 2010
Figure 5-10: India - Biopharmaceutical Market by Segment (%), FY 2007
Figure 5-11: India - Forecast for Biotechnology Market by Segment (%), FY 2013
Figure 5-12: India - Geographical Distribution of Bio-clusters
Figure 5-13: Australia - Biotechnology Market (Billion US$), 2009-2013
Figure 5-14: Australia - Biotechnology Companies by Sector (%), 2010
Figure 5-15: Australia - Geographical Distribution of Bio-clusters
Figure 5-16: Taiwan - Biotechnology Market (Billion NT$), 2008-2013
Figure 5-17: South Korea - Biotechnology Market (Billion US$), 2010-2013
Figure 5-18: South Korea - Biotechnology Market by Segment (%)
Figure 5-19: South Korea - Geographical Distribution of Bio-clusters
Figure 5-20: New Zealand - Biotechnology Market (Million US$), 2009-2013
Figure 5-21: New Zealand - Biotechnology Market by Application (%), 2010
Figure 5-22: New Zealand - Biotechnology Companies by Sector (%), 2007
Figure 5-23: New Zealand - Geographical Distribution of Bio-clusters
Figure 5-24: Singapore - Biotechnology Market (Million US$), 2008-2013
Figure 5-25: Singapore - Geographical Distribution of Bio-clusters
Figure 5-26: Malaysia - Biotechnology Market (Million RM), 2008-2013
Figure 5-27: Malaysia - Biotechnology Industry Investment by Segment (%)
LIST OF TABLES:
Table 5-1: DBT Funded Research Projects/Companies
Table 5-1: DBT Funded Research Projects/Companies
